Ever since radioimmunoassay for hum an chorio gonadotropin (hCG) was developed [1], num erous attempts have been m ade to increase the specificity of hCG assay. H um an choriogonadotropin, like other glycoprotein hormones, lutropin (LH), follitropin (FSH) and thyrotropin (TSH), consists of two dissimilar subunits designated a and ß [2] , Their a-subunits are almost identical in amino acid se quences, differing only in the type o f monosaccha rides present and the structure o f oligosaccharide units located at specific amino acid residues in the polypeptide chains [3] . Due to this extensive struc tural homology, antisera raised against native hCG invariably cross-react with hum an LH (hLH), hum an TSH (hTSH) and hum an FSH (hFSH). With the recognition that the ^-subunits o f glyco protein hormone confer hormonal specificity and that the free /?-subunit of hCG is a much more specific antigen than hCG, anti-hCG-/? sera have replaced anti-hCG sera in radioim m unoassays for hCG. Although a n ti-\iC G -ß sera are able to dis criminate hCG from hLH to a greater extent than anti-hCG sera [4] , they have about 10 to 30% cross reaction with hLH. Because of this cross-reaction it is difficult to make accurate determ inations of hCG in serum when the levels of the hormone are low. While the immunological cross-reactivity of antihCG sera with other glycoprotein hormones hFSH and hTSH is prim arily due to the identical oc-subunit, that with hLH however is also the result of considerable structural homology in their ^-subunits.
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During the course o f our studies on the structureactivity relationships in hCG-/?, among the many chemically m odified derivatives of hCG-/? tested, D S5-hCG-/?, the reduced and S-carboxyamidomethylated derivative in which 5 out of 6 disulfide bonds had been m odified did not show cross-reactivity in the [l25I]-hLH-arc//-hLH radioimmunoassay (RIA) system [5, 6] . It did, however, effectively inhibit the binding [ 125I]-hCG to hCG antibodies [5, 6] , This observation relating to the selective destruction of hC G /hL H determ inants by chemical modification of hCG-/? and retention of hCG determ inants in D S5-hCG-/? suggested that im m unization o f rab bits against DS5-hCG-/? might yield an antiserum specific to hCG. Such an antiserum was indeed produced in rabbits and shown to be highly specific to hCG by immunological and biological criteria [7] . Further, the affinity and titer o f the antibody was high. Hence, the present work was undertaken to establish RIA using this antiserum for m easuring hCG. The characteristics o f this RIA and the results of its application to various clinical samples are described below.
M aterials and Methods
Highly purified hCG (L-129, 12500 IU /m g) was prepared from a crude commercial preparation of hCG with a potency of 31001U/mg (Organon, West Orange, New Jersey) essentially according to Bahl [8] except that a pH o f 7.4 was m aintained throughout the purification. Hum an LH (LER 960) was obtained from the N ational Pituitary Agency through the Hormone D istribution Officer o f the National Institute of Arthritis, M etabolic and D i gestive Diseases, the National Institutes of Health, Bethesda, USA. Pergonal (75 1U of FSH + 75 1U of LH/am poule) was purchased from Serono L abo ratories, USA. Carrier free N a l25I was obtained from the Radio-Chem ical Center, Amersham. Bovine serum albumin (BSA) and bovine gam m a globulin were purchased from Sigma Chem ical Co., St. Louis, USA. All other chemicals were o f certi fied analytical grade.
Serum samples
Serum samples were obtained from pregnant women who came into clinics. Sera were also obtained from normal adult healthy male subjects, from women in post-partum stage (around one month after parturition) and from post-m enopausal women.
Tissue extracts
Tissues removed from hum an subjects at autopsy were immediately frozen in dry ice, transported to the laboratory and stored frozen at -70 °C. They were extracted and assayed within a day after their removal from the body. Two extraction procedures were chosen. In the first procedure frozen tissues were minced into small pieces before homogenization in a Potter-Elvehjem tissue grinder in 0.1 m sodi um borate buffer, pH 8.4. The homogenates were centrifugated at 10000 x g for 15 min at 4 °C and the supem atants were assayed for hCG by the RIA. The second procedure was essentially that of Yoshimoto et al. [9] with m inor modifications. Briefly, the tissues were extracted with 5 volumes of glacial acetic acid using a W aring Blendor. The hom o genates were kept in a shaking water bath at 80 °C for 30 min before centrifugation at 10000 x g for 15 min at 4°C . The supernatants were lyophilized. The lyophilized materials were suspended in O .In H C I and kept stirred for 30 min at 20 °C followed by centrifugation at 5000 x g for 15 min at 4 °C. The pH of the supernatants were adjusted to 7.5 to 8.0 using NaOH. The extracts were adjusted to 1 gm tissue/ml and then assayed in duplicate by the RIA.
Production o f antiserum
The details of the preparation of D S5-hCG-/? and DS6-hCH-/? by controlled and complete reduction and S-alkylation of h C G -ß have been described elsewhere [6] . Briefly, hCG was dissociated into aand /?-subunits using 8 m urea and the subunits were separated by chrom atography on DEAE-Sephadex [8] . The /?-subunit was further purified by second urea treatment and chrom atography on Sephadex-G 100. Residual contam ination with hCG (as in dicated by radioreceptor assay) in h C G -ß was re moved by treating hCG-/? with an immunoadsorbent of anti-hC G -a serum prepared by coupling the y-globulin fraction of this serum to CNBractivated Sepharose [10] . Subsequently the hCG-/? subunit was reduced partially (5 out of 6 disulfide bonds to prepare D S5-hCG-/?) with dithioerythritol followed by S-alkylation of the free SH groups with iodoacetam ide [6] . The D S5-hCG-/? and DS6-hCG-/? preparations were then desalted on a column of Sephadex-G-25. The D S5-hCG-/? was treated with an im m unoadsorbent of arc//-LH-serum to remove any unreduced h C G -ß [5] . The purified D S5-hCG-/? was conjugated to hemocyanin and the resulting conjugate was used as an immugen to generate antibodies in rabbits by periodic intra muscular injections. The antigen was emulsified with Freund's complete adjuvant before each injec tion. The rabbits were boosted either with D S5-hCG-/? or DS6-hCG-/?. Hence the antiserum will be hereafter referred to as D S5, DS6-hCG-/?-hem serum. Periodically samples of blood were drawn from the ear vein and serum collected. 200 pi of serum at various dilutions (1:10 to 1:10000) was incubated with [l25I]-hCG for l h at 37 °C followed by the addition of 100 pi of 1% bovine gamma globulin solution and 1 ml o f 10% am m o nium acetate in ethanol. The tubes were kept for 1 h at 4 °C, then centrifuged, supem atants decanted, residual liquid removed by wiping with filter paper strips and finally pellets were counted for antibody bound radioactivity. The dilution of the antiserum binding 20% of the [i25I]-hCG (40 -50 pC i/pg) was chosen for RIA. The radioimmunoassay was rou tinely conducted with 1:5000 diluted anti-D S5, D S6-hCG-/?-hem serum.
Radioiodination and radioimmunoassay
The radioiodination of highly purified hC G was performed by the chloramine-T procedure of Greenwood et al. [11] with minor modifications. To 10 pg of hCG in 10 pi of water was added 20 pi of 0.5 M sodium phosphate buffer, pH 7. -hCG (50000 cpm) for 1 h at 37 °C followed by 16 h at 4 °C. All dilutions were done in 0.1 M sodium borate buffer pH 8.4 containing 0.5% BSA (hereafter referred to as RIA buffer). At the end of the incubation 100 pi of 1% bovine gam m a globulin prepared in RIA buffer were added to all tubes followed by 1.4 ml of 10% am m onium acetate in ethanol (resulting in 6.6% of final concentration of ammonium acetate and 66% of final concentra tion of ethanol). The tubes after vortexing were kept at 4°C for 1 h followed by centrifugation at 2000 x g for 15 min at 4 °C. The supernatants were then decanted, and the traces of liquid on the walls of the tubes were removed by wiping with paper strips. The pellets were counted for antibody bound radioactivity. Suitable controls without antiserum (for standards) and without antiserum but with sera or tissue extracts (for unknown sera and tissue extracts) were also routinely included in the assay. The results were expressed as B/B0x 100 and plotted against log dose of hCG standards. B0 represents cpm radioactivity bound in the absence of any competing antigen and B represents cpm radio activity bound in the presence of various levels of competing standard hCG or unknown sample. The radioimmunoassay data were also analyzed by a computer, Wang Model 2200, using program RIADS-2200, based on the method developed by Rodbard and Lewald [13] .
Results

Specificity o f the radioimmunoassay
The specificity of the present radioimmunoassay for hCG was evaluated in a num ber of ways. W hen serum samples from adult hum an male volunteers and from post-partum women were assayed for hCG, there was no detectable hCG (data not shown). These samples are known to have normal physiological levels of hLH which apparently did not interfere in the assay. In an extension of this study serum samples and urinary concentrates con taining high levels of hLH were also tested in the present RIA. It was found that neither post-meno pausal women's sera nor Pergonal, a commercial preparation of hum an menopausal urinary gonado tropin had any detectable hC G (data not shown). The sera were always assayed in duplicate or tri plicate and at various doses (e.g. normal serum and 1:2, 1:4, 1:8, 1:16 and 1:32 or higher dilutions). In order to know whether the present RIA offers any advantage over the conventional RIA using antih C G -ß serum with regard to the interference by hLH, both the RIAs were perform ed with hLH as standard. As indicated in Fig. 1, hLH (Fig. 1) .
Sensitivity o f the RIA
The radioimmunoassays were routinely perform ed using 1:5000 diluted anti-D S5, D S6-hCG-/?-hem serum. The sensitivity o f the RIA was high as the minimal detection lim it was 0.2 ng/tube or 1 ng/m l (using a highly purified hCG preparation, L-129 as standard). Using WHO international reference pre paration, this am ounted to 12m IU /m l. The preci sion of measurement of each point on the standard curve is given in Table I . The standard deviations about each point indicates that the present RIA is characterized by good precision and high sensitivity with a reproducible standard curve.
Measurement ofh C G in serum samples
Initially, the RIA was characterized by measuring hCG in three pools of sera containing high, m iddle and low levels of hCG. Each of the samples was assayed at 4 to 5 dose levels and in triplicate at each dose level. Assay was repeated for each sample on different days in order to determine intra-assay and inter-assay variations. Results were expressed as / S.D. \ coefficient of variation -------x 100 . The intra-\ mean / assay variations for each of the samples are in dicated under Table II . The low pool samples was assayed at 1:2, 1:4, 1:5 dilutions, the middle pool at 1:5, 1:10, 1:20 dilutions, and high pool at 1:20, 1:40, 1:50, 1:100 dilutions. The intra-assay and inter-assay coefficients of variation were determ ined both from these three pools of sera and from sera from pregnant women at various gestational ages. As indicated in Table II , these values ranged from 6.9% to 16.6%. In order to further characterize the RIA with regard to realiability, serial dilutions o f a pooled serum sample of hCG (at 1:10 to 1:5120 dilutions) were assayed in triplicate. The inhibition curve obtained was com pared to the standard inhibition curve obtained with hCG. As indicated by Fig. 2 , the immunoreactive material in the serum gave an inhibition curve parallel to that given by standard hCG indicating that hC G like m aterial was being measured in the serum sample.
Subsequently, sera collected from pregnant women at various stages o f gestation were assayed for hCG levels. Assays were always conducted in duplicate or triplicate for each sample and at more than one dose level. The results (not presented here) are generally in agreement with the reported circu latory levels o f hCG during gestation in women [1, 14] ,
Application to tissues extracts
Extracts o f tissues rem oved at autopsy from two apparently "norm al" hum an subjects were assayed for possible presence of hC G -like m aterial in view of the recent reports that such a material was present in many normal, non-cancerous hum an tissues [9, 15, 16] . The results indicated that no cross-reactive material was detectable at the levels (data not shown). In contrast, when an extract of hum an term placenta was used as a control, an expected quantity of hCG was found to be present (data not shown).
Discussion
The existing radioimmunoassays based on antihCG-A for the quantitation of hCG in serum samples suffer from a drawback in that hLH inter feres in the assays to varying extent [17] . Owing to the structural homology between hCG-/? and hLH-/? [5] it is not surprising to find such a cross-reaction. The specificity of an RIA is a function of the specificity of the antibody or that of the antigen used to raise the antibody. HCG or hCG-/? does not generally elicit such specific antibodies. Conse quently, in order to prepare specific antigen(s) from hCG-/?, two approaches have been taken. Since one of the major differences between hLH-/? and hCG-/? is the presence of a unique 30 amino acid residue peptide at the carboxy-terminus of the latter, one approach involved the use of this peptide as an antigen to elicit specific antibodies. The second approach was based on the use of the chemically modified analogs of hCG-/? as antigens [23] . The ü«7/-carboxyterminal peptide sera were found to vary in their specificity, sensitivity and in their ability to neutralize hCG depending on the length of the peptide used as an antigen. Peptides of 35 amino acid residues (residues 111 -145) or longer yielded antisera which were able to neutralize the biological activity o f hCG [18] and thus appear to have potential in fertility regulation. Peptides shorter than 35 amino acid residues (residues 116-145 or less) generate specific antibodies of low titer and lack the ability to neutralize hCG. In general, the specific antisera for hCG and therefore, the RIA based on these antisera are not sensitive enough to detect early pregnancy.
The second approach of using a chemically m odi fied form of hCG-/? for im m unization yielded promising results. It was earlier shown by us that among the various derivatives o f hCG-/? prepared and tested, D S5-hCG-/? did not interfere in the [l25I]-hLH-fl«//-hLH RIA system [5] . The rabbit antibodies to this analog of hCG-/? were specific to hCG as shown by the lack of cross-reactivity with other hormones like hCG -a, hTSH, hPRL, hFSH in the RIA [7] . The im m unogeneity of these deriv atives in which the tertiary structure has been affected to a great extent was reduced considerably when compared to that of native hCG-/? subunit. Hence, the derivative was conjugated to key hole limpet haem ocyanin and the conjugate was used as immunogen. The boosting was done with the deriv ative alone in order to increase the antibody popula tion against the antigenic determ inant(s) on the hormone rather than against the haemocyanin. Because of the reasonably high titers achieved now, it was considered useful to characterize the anti-D S5, DS6-hCG-/?-hem-[125I]-hCG RIA system further and apply it to the m easurem ent of hCG in blood and tissues. The minimal detection lim it of the RIA was 10-12m IU /m l which is much lower than what has been achieved in RIA using anticarboxy-terminal peptide sera. The sensitivity of the assay, if neeed, can be further enhanced by using [l25I]-hCG of higher specific radioactivity (8 0 -1 0 0 nCi/|ig) than the one employed here (40 -50 (iCi/ng). M atsuura et al. [19] using antisera H-93 and H-l 14 which were raised against the natural carboxy-terminal peptide isolated from hCG-/? subunit and the synthetic N-a-acetyl triaconatpeptide analogous to the carboxy-terminal region (residues 116-145) respectively reported a minimal detection lim it of 19.4 and 31.5ng/m l respectively.
The specificity o f the present RIA for h C G / hCG-/? is indicated by the fact that hLH in any form either as standard (up to 100 ng/m l), in serum (normal male serum or post-m enopausal women's serum) or as a urinary extract (Pergonal, up to 50 m lU of hLH and hFSH) did not interfere in the assay. From our prelim inary studies, it appears that the antibody to D S5, D S6-hCG-/?-hem is directed against an antigenic site in the N -terminal region [23] . Apparently, this seems to be the molecular basis underlying the specificity of the anti-D S 5, DS6-hCG-/?.
Using RIAs involving antisera to carboxyterminal peptides, hCG or hC G -like materials have been detected in a variety of non-trophoblastic and non-cancerous tissues including human pituitary glands [9, 15, 16] . Although McManus et al. [20] could not detect hCG or hC G -like materials in normal human tissues, these authors and others [21] using peroxidase labelled antibodies or im m uno fluorescence techniques have been successful in locating such materials on many tum or cell m em branes. We have examined liver, colon and lung tissues from two apparently "norm al" individuals (accident victims) with our RIA and have not found hCG or hCG-like material at the tissue levels tested. It may be added that the negative results are not due to the two procedures used for the extrac tion of the tissues since the hum an term placenta extracted similarly gave values which were in agree ment with those reported by others [22] . Based on these limited studies, one cannot be sure of the presence or absence of hC G or hCG -like materials in normal hum an tissues. This question can only be resolved unequivocally by examining a large pool and by the dem onstration of hCG or hCG -like material by further physicochemical and biological characterization. The present RIA system involving anti-D S5, DS6-hCG-/?-hem serum offers a consider able advantage in specificity, sensitivity and repro ducibility over the other RIA systems using antihCG-/? or an ti-peptide sera. Consequently, not only it should prove to be highly useful in the early detection of pregnancy but also in the early diag nosis and the treatm ent of certain malignancies.
